Primary acquired sideroblastic anaemia: response to treatment with pyridoxal-5-phosphate.
A 72-year-old woman with primary sideroblastic anaemia showed no response to treatment with pyridoxine. When she was given pyridoxal-5-phosphate there was a prompt reticulocyte response and sustained symptomatic improvement with satisfactory control of the anaemia.
D000368:Aged; D000756:Anemia, Sideroblastic / Q000188:drug therapy*; D001205:Ascorbic Acid / Q000627:therapeutic use; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D006452:Hemoglobinometry; D006801:Humans; D011732:Pyridoxal Phosphate / Q000627:therapeutic use*; D011736:Pyridoxine / Q000627:therapeutic use; D012156:Reticulocytes; D014364:Tryptophan / Q000627:therapeutic use
D011732:Pyridoxal Phosphate; D014364:Tryptophan; D005492:Folic Acid; D011736:Pyridoxine; D001205:Ascorbic Acid